Randomised, double-blind, placebo controlled, phase III, parallel group study in gay men using 5% Imiquimod for the treatment of high-grade anal intraepithelial neoplasia (AIN 2/3)

Mise à jour : Il y a 4 ans
Référence : ISRCTN96401551